Validation pour Ingenuity075

vers la météo de la validation par utilisateur

Ingenuity075

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 64 - PMID ?

Cholangiocarcinoma in humans is associated with downregulation of SP NODE mRNA in cholangiocarcinoma cell lines .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                                      +-------------------------------COMP:V_PASS-N(in)------------------------------+    
                                      |                 +--------COMP:N-N(of)--------+                               |    
                                      |                 |             +-MOD_ATT:N-ADJ+              +---MOD_ATT:N-N--+    
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wit+             |       +MOD_AT+              |           +MOD_+    
          |                           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,line)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 1

                                                                              +-------------COMP:V-N(in)-------------+    
                          +----------------------SUBJ:V-N---------------------+                     +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +OBJ:V-+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V_PASS-N (associate,human)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,__SP__)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 2

                                      +---------------------------------COMP:V-N(in)---------------------------------+    
                                      |                 +--------COMP:N-N(of)--------+                               |    
                                      |                 |             +-MOD_ATT:N-ADJ+              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             |       +MOD_AT+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
COMP:V-N(in) (associate,line)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 3

                          +----------------------SUBJ:V-N---------------------+-------------COMP:V-N(in)-------------+    
                          +----------------COMP:N-N(of)---------------+       |                     +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +OBJ:V-+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(of) (human,__SP__)
SUBJ:V_PASS-N (associate,human)
COMP:V_PASS-N(with) (associate,downregulation)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 4

                                                        +--------COMP:N-N(of)--------+----------COMP:N-N(in)---------+    
                                                        |             +-MOD_ATT:N-ADJ+              +---MOD_ATT:N-N--+    
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wit+             |       +MOD_AT+              |           +MOD_+    
          |                           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 5

                                                        +--------COMP:N-N(of)--------+----------COMP:N-N(in)---------+    
                                                        |             +-MOD_ATT:N-ADJ+              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             |       +MOD_AT+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 6

                                                        +------------------------COMP:N-N(in)------------------------+    
                                                        +--------COMP:N-N(of)--------+                               |    
                                                        |             +-MOD_ATT:N-ADJ+              +---MOD_ATT:N-N--+    
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wit+             |       +MOD_AT+              |           +MOD_+    
          |                           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,line)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 7

                                                        +--------COMP:N-N(of)--------+                                    
                                                        |             +-MOD_ATT:N-ADJ+              +---MOD_ATT:N-N--+    
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wit+             |       +MOD_AT+              |           +MOD_+    
          |                           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 8

                                                                                     +----------COMP:N-N(in)---------+    
                          +----------------------SUBJ:V-N---------------------+      |              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +OBJ:V-+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V_PASS-N (associate,human)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,__SP__)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 9

                                                        +------------------------COMP:N-N(in)------------------------+    
                                                        +--------COMP:N-N(of)--------+                               |    
                                                        |             +-MOD_ATT:N-ADJ+              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             |       +MOD_AT+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,line)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 10

                                                        +--------COMP:N-N(of)--------+                                    
                                                        |             +-MOD_ATT:N-ADJ+              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             |       +MOD_AT+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 11

                          +----------------------SUBJ:V-N---------------------+-------------COMP:V-N(in)-------------+    
                          +--------COMP:N-N(with)-------+                     |                     +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+SUBJ:V_PASS+                 +-COMP:N-N(of)+       +OBJ:V-+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(with) (human,downregulation)
SUBJ:V_PASS-N (associate,human)
COMP:N-N(of) (downregulation,__SP__)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 12

                          +----------------------SUBJ:V-N---------------------+      +----------COMP:N-N(in)---------+    
                          +----------------COMP:N-N(of)---------------+       |      |              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +OBJ:V-+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(of) (human,__SP__)
SUBJ:V_PASS-N (associate,human)
COMP:V_PASS-N(with) (associate,downregulation)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 13

                                                        +--------COMP:N-N(of)--------+                                    
                               +--------SUBJ:V-N--------+             +-MOD_ATT:N-ADJ+              +---MOD_ATT:N-N--+    
                               |      +--MOD_ATT:N-ADJ--+             |       +MOD_AT+              |           +MOD_+    
                               |      |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V-N (be,downregulation)
MOD_ATT:N-ADJ (downregulation,associate)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 14

                          +----------------------SUBJ:V-N---------------------+                                           
                          +----------------COMP:N-N(of)---------------+       +-------------COMP:V-N(in)-------------+    
                          +--------COMP:N-N(with)-------+             |       |                     +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+SUBJ:V_PASS+                 |             |       +OBJ:V-+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(with) (human,downregulation)
COMP:N-N(of) (human,__SP__)
SUBJ:V_PASS-N (associate,human)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 15

                                                        +--------COMP:N-N(of)--------+----------COMP:N-N(in)---------+    
                               +--------SUBJ:V-N--------+             +-MOD_ATT:N-ADJ+              +---MOD_ATT:N-N--+    
                               |      +--MOD_ATT:N-ADJ--+             |       +MOD_AT+              |           +MOD_+    
                               |      |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V-N (be,downregulation)
MOD_ATT:N-ADJ (downregulation,associate)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 16

                                      +-------------------------------COMP:V_PASS-N(in)------------------------------+    
                                      |       +----------------OBJ:V-N---------------+              +---MOD_ATT:N-N--+    
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+              |           +MOD_+    
          |                           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,line)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 17

                          +----------------------SUBJ:V-N---------------------+      +----------COMP:N-N(in)---------+    
                          +--------COMP:N-N(with)-------+                     |      |              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+SUBJ:V_PASS+                 +-COMP:N-N(of)+       +OBJ:V-+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(with) (human,downregulation)
SUBJ:V_PASS-N (associate,human)
COMP:N-N(of) (downregulation,__SP__)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 18

                                                        +------------------------COMP:N-N(in)------------------------+    
                                                        +--------COMP:N-N(of)--------+                               |    
                               +--------SUBJ:V-N--------+             +-MOD_ATT:N-ADJ+              +---MOD_ATT:N-N--+    
                               |      +--MOD_ATT:N-ADJ--+             |       +MOD_AT+              |           +MOD_+    
                               |      |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V-N (be,downregulation)
MOD_ATT:N-ADJ (downregulation,associate)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,line)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 19

                                      +-------------------------------COMP:V_PASS-N(in)------------------------------+    
                                      |       +----------------OBJ:V-N---------------+                               |    
                                      |       |         +-----COMP:N-N(of)----+      |              +---MOD_ATT:N-N--+    
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wit+             +MOD_ATT+      |              |           +MOD_+    
          |                           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,line)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 20

                                      +---------------------------------COMP:V-N(in)---------------------------------+    
                                      |       +----------------OBJ:V-N---------------+              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+-COMP:N-N(of)+       +MOD_AT+              |           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
COMP:V-N(in) (associate,line)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 21

                                      +---------------------------------COMP:V-N(in)---------------------------------+    
                                      +--------------------OBJ:V-N-------------------+              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+-COMP:N-N(of)+       +MOD_AT+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,mRNA)
COMP:V-N(in) (associate,line)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 22

                                      +---------------------------------COMP:V-N(in)---------------------------------+    
                                      |       +----------------OBJ:V-N---------------+                               |    
                                      |       |         +-----COMP:N-N(of)----+      |              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             +MOD_ATT+      |              |           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
COMP:V-N(in) (associate,line)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 23

                                      +---------------------------------COMP:V-N(in)---------------------------------+    
                                      +--------------------OBJ:V-N-------------------+                               |    
                                      |                 +-----COMP:N-N(of)----+      |              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             +MOD_ATT+      |              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,mRNA)
COMP:V-N(in) (associate,line)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 24

                          +----------------------SUBJ:V-N---------------------+                                           
                          +----------------COMP:N-N(of)---------------+       |      +----------COMP:N-N(in)---------+    
                          +--------COMP:N-N(with)-------+             |       |      |              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+SUBJ:V_PASS+                 |             |       +OBJ:V-+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(with) (human,downregulation)
COMP:N-N(of) (human,__SP__)
SUBJ:V_PASS-N (associate,human)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 25

                                      +------------------------------------OBJ:V-N-----------------------------------+    
                                      +-------------------------COMP:V-N(in)------------------------+                |    
                                      |                 +--------COMP:N-N(of)--------+              |                |    
                                      |                 |             +-MOD_ATT:N-ADJ+              |                |    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             |       +MOD_AT+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
COMP:V-N(in) (associate,cholangiocarcinoma)
OBJ:V-N (associate,line)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cell)

Analyse 26

                                                                                     +----------COMP:N-N(in)---------+    
                                              +----------------OBJ:V-N---------------+              +---MOD_ATT:N-N--+    
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+              |           +MOD_+    
          |                           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 27

                                              +----------------OBJ:V-N---------------+----------COMP:N-N(in)---------+    
                                              |         +-----COMP:N-N(of)----+      |              +---MOD_ATT:N-N--+    
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wit+             +MOD_ATT+      |              |           +MOD_+    
          |                           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 28

                                                                                     +----------COMP:N-N(in)---------+    
                                              +----------------OBJ:V-N---------------+              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+-COMP:N-N(of)+       +MOD_AT+              |           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 29

                                                                                     +----------COMP:N-N(in)---------+    
                                      +--------------------OBJ:V-N-------------------+              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+-COMP:N-N(of)+       +MOD_AT+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 30

                                              +----------------OBJ:V-N---------------+----------COMP:N-N(in)---------+    
                                              |         +-----COMP:N-N(of)----+      |              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             +MOD_ATT+      |              |           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 31

                                              +--------------------------------OBJ:V-N-------------------------------+    
                                              |         +--------COMP:N-N(of)--------+                               |    
                                              |         |             +-MOD_ATT:N-ADJ+                               |    
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wit+             |       +MOD_AT+-COMP:N-N(in)-+           +MOD_+    
          |                           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,line)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 32

                                      +--------------------OBJ:V-N-------------------+----------COMP:N-N(in)---------+    
                                      |                 +-----COMP:N-N(of)----+      |              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             +MOD_ATT+      |              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 33

                                              +--------------------------------OBJ:V-N-------------------------------+    
                                              |         +--------COMP:N-N(of)--------+                               |    
                                              |         |             +-MOD_ATT:N-ADJ+                               |    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             |       +MOD_AT+-COMP:N-N(in)-+           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (with,line)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 34

                                      +------------------------------------OBJ:V-N-----------------------------------+    
                                      |                 +--------COMP:N-N(of)--------+                               |    
                                      |                 |             +-MOD_ATT:N-ADJ+                               |    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             |       +MOD_AT+-COMP:N-N(in)-+           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,line)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 35

                                              +--------------------------------OBJ:V-N-------------------------------+    
                                              |         +----------------COMP:N-N(in)---------------+                |    
                                              |         +--------COMP:N-N(of)--------+              |                |    
                                              |         |             +-MOD_ATT:N-ADJ+              |                |    
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wit+             |       +MOD_AT+              |           +MOD_+    
          |                           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,line)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,cholangiocarcinoma)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cell)

Analyse 36

                                              +--------------------------------OBJ:V-N-------------------------------+    
                                              |         +----------------COMP:N-N(in)---------------+                |    
                                              |         +--------COMP:N-N(of)--------+              |                |    
                                              |         |             +-MOD_ATT:N-ADJ+              |                |    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             |       +MOD_AT+              |           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (with,line)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,cholangiocarcinoma)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cell)

Analyse 37

                                      +------------------------------------OBJ:V-N-----------------------------------+    
                                      |                 +----------------COMP:N-N(in)---------------+                |    
                                      |                 +--------COMP:N-N(of)--------+              |                |    
                                      |                 |             +-MOD_ATT:N-ADJ+              |                |    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             |       +MOD_AT+              |           +MOD_+    
          |               |           |                 |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,line)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,cholangiocarcinoma)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cell)

Analyse 38

                                      +---------------------------------COMP:V-N(in)---------------------------------+    
                                      +--------------------OBJ:V-N-------------------+              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+-COMP:N-N(of)+              |              |           +MOD_+    
          |               |           |                 |             |              |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,mRNA)
COMP:V-N(in) (associate,line)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 39

                                      +------------------------------------OBJ:V-N-----------------------------------+    
                                      |                 +--------COMP:N-N(of)--------+                               |    
                                      |                 |             +-MOD_ATT:N-ADJ+                               |    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             |       +MOD_AT+                          +MOD_+    
          |               |           |                 |             |       |      |                          |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,line)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cell)

Analyse 40

                                                                                     +----------COMP:N-N(in)---------+    
                                      +--------------------OBJ:V-N-------------------+              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+-COMP:N-N(of)+              |              |           +MOD_+    
          |               |           |                 |             |              |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,mRNA)
COMP:N-N(of) (downregulation,__SP__)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 41

                                      +---------------------------------COMP:V-N(in)---------------------------------+    
                                      +--------------------OBJ:V-N-------------------+                               |    
                                      |       +------------OBJ:V-N------------+      |              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+-COMP:N-N(of)+       |      |              |           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,mRNA)
COMP:V-N(in) (associate,line)
OBJ:V-N (with,__NODE__)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 42

                                      +------------------------------------OBJ:V-N-----------------------------------+    
                                      +-------------------------COMP:V-N(in)------------------------+                |    
                                      |       +----------------OBJ:V-N---------------+              |                |    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+-COMP:N-N(of)+       +MOD_AT+              |           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
COMP:V-N(in) (associate,cholangiocarcinoma)
OBJ:V-N (associate,line)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (line,cell)

Analyse 43

                                      +------------------------------------OBJ:V-N-----------------------------------+    
                                      +-------------------------COMP:V-N(in)------------------------+                |    
                                      |       +----------------OBJ:V-N---------------+              |                |    
                                      |       |         +-----COMP:N-N(of)----+      |              |                |    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             +MOD_ATT+      |              |           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
COMP:V-N(in) (associate,cholangiocarcinoma)
OBJ:V-N (associate,line)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (line,cell)

Analyse 44

                                      +--------------------OBJ:V-N-------------------+----------COMP:N-N(in)---------+    
                                      |       +------------OBJ:V-N------------+      |              +---MOD_ATT:N-N--+    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+-COMP:N-N(of)+       |      |              |           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,mRNA)
OBJ:V-N (with,__NODE__)
COMP:N-N(of) (downregulation,__SP__)
COMP:N-N(in) (mRNA,line)
MOD_ATT:N-N (line,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 45

                                      +------------------------------------OBJ:V-N-----------------------------------+    
                                      |       +----------------OBJ:V-N---------------+                               |    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+-COMP:N-N(of)+       +MOD_AT+-COMP:N-N(in)-+           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,line)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)

Analyse 46

                                      +------------------------------------OBJ:V-N-----------------------------------+    
                                      |       +----------------OBJ:V-N---------------+                               |    
                                      |       |         +-----COMP:N-N(of)----+      |                               |    
          +--MOD_ATT:N-N--+--SUBJ:V-N-+--COMP:V-N(with)-+             +MOD_ATT+      +-COMP:N-N(in)-+           +MOD_+    
          |               |           |       |         |             |       |      |              |           |    |    
 Cholangiocarcinoma in humans is associated with downregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,downregulation)
OBJ:V-N (associate,line)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)
MOD_ATT:N-N (line,cell)